EUVIMEDEUVIMED entdecken
Open Access

Unveiling the enzymatic activity of a dimeric LDH isoform and its implications for allosteric inhibition strategies

Ferran Nadal-Bufi iD, Mégane Van Gysel, Chiara Brustenga, Perrine Savoyen, Caroline Mathieu, Alexandre Gobert, Pierre Sonveaux, Quentin Spillier, Marianne Fillet, Johan Wouters, Raphaël Frédérick iD

Protein Science · 2025

DOI: 10.1002/pro.70367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2025. Verfasst von Ferran Nadal-Bufi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Research Group (CMFA), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCLouvain), Brussels, Belgium. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Protein Multimerization, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: French Community of Belgium, Belgian Fonds National de la Recherche Scientifique, Belgian Fondation contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactate dehydrogenase (LDH) is a key enzyme in cancer metabolism, with isoforms LDH5 and LDH1 supporting glycolysis and oxidative lactate metabolism, respectively. While the development of competitive LDH inhibitors has faced diverse challenges, allosteric strategies targeting LDH tetramerization have recently attracted increasing attention. To further explore this alternative, we investigated the factors influencing LDH tetramerization and enzymatic activity using a truncated form of human LDH‐B (LDHBtr), which was reported to exist predominantly as a dimer. Unexpectedly, LDHBtr exhibited measurable activity at high concentrations, correlating with increased protein stability and a structural transition to the tetrameric form. Preincubation with NADH further enhanced LDHBtr activity, stability, and self‐association, consistent with cofactor‐promoted tetramer assembly. Crystallographic studies confirmed the tetrameric structure of LDHBtr bound to NADH. Furthermore, reported LDH allosteric inhibitors, including cGmC9 and fluoxetine, preferentially inhibited LDHBtr compared to the native LDHB, by preventing tetramer formation. Overall, this work highlights the central role of tetramerization in regulating LDH activity, and the therapeutic potential of targeting this process. It also establishes LDHBtr as a valuable tool for screening tetramerization disruptors, paving the way for next‐generation LDH inhibitors to target cancer metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

L-Lactate DehydrogenaseProtein MultimerizationEnzyme InhibitorsHumansAllosteric RegulationIsoenzymesNADCrystallography, X-RayModels, Molecular

Stichwörter der Autor:innen

allosteric inhibitioncancer metabolismenzyme regulationlactate dehydrogenaseprotein–protein interactionstetramerization

Substanzen

L-Lactate DehydrogenaseIsoenzymesNADEnzyme Inhibitors

Autor:innen und Institutionen

  • Medicinal Chemistry Research Group (CMFA), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Namur Institute of Structured Matter and Namur Research Institute for Life Sciences, Department of Chemistry, University of Namur, Namur, Belgium.
  • Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • WEL Research Institute, WELBIO Department, Wavre, Belgium.
  • Laboratory for the Analysis of Medicines (CIRM), University of Liege (ULiege), Liège, Belgium.

ORCID-Profile: Ferran Nadal-Bufi, Raphaël Frédérick

Förderung

  • French Community of Belgium
  • Belgian Fonds National de la Recherche Scientifique
  • Belgian Fondation contre le Cancer
  • Télévie
  • Fédération Wallonie-Bruxelles

Zitieren

APA

Nadal-Bufi, F., Van Gysel, M., Brustenga, C., Savoyen, P., Mathieu, C., Gobert, A., Sonveaux, P., Spillier, Q., Fillet, M., Wouters, J., & Frédérick, R. (2025). Unveiling the enzymatic activity of a dimeric LDH isoform and its implications for allosteric inhibition strategies. Protein Science. https://doi.org/10.1002/pro.70367

Vancouver

Nadal-Bufi F, Van Gysel M, Brustenga C, Savoyen P, Mathieu C, Gobert A, et al. Unveiling the enzymatic activity of a dimeric LDH isoform and its implications for allosteric inhibition strategies. Protein Science. 2025. doi:10.1002/pro.70367

BibTeX
@article{NadalBufi2025,
  author = {Nadal-Bufi, Ferran and Van Gysel, Mégane and Brustenga, Chiara and Savoyen, Perrine and Mathieu, Caroline and Gobert, Alexandre and Sonveaux, Pierre and Spillier, Quentin and Fillet, Marianne and Wouters, Johan and Frédérick, Raphaël},
  title = {Unveiling the enzymatic activity of a dimeric LDH isoform and its implications for allosteric inhibition strategies},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70367}
}
Kostenlos starten →